Sara Kohlbeck, MPH; Brenna Akert, BS; Caroline Pace, MD; Amy Zosel, MD, MSCS
WMJ. 2018;117(1):38-41.
ABSTRACT
Introduction: The Wisconsin Prescription Drug Monitoring Program (PDMP) was implemented in 2013 to reduce the misuse, abuse, and diversion of controlled substance prescriptions.
Objective: To evaluate provider knowledge, attitudes, and behaviors regarding the Wisconsin PDMP before and after study interventions.
Methods: An initial survey of clinicians, a focus group, pre- and posttests for an educational session, and a 3-month follow-up survey were utilized.
Results: Initial survey participants described PDMP use. Focus group themes included system, hospital, clinician, and patient factors. Educational session pre- and posttests showed an increase in provider knowledge. Follow-up surveys demonstrated practice change among providers.
Conclusion: This study can be useful for health care organizations, state PDMPs, and prevention organizations in tailoring messaging to clinicians around safe prescribing and PDMP use.
Author Affiliations: Department of Emergency Medicine, Medical College of Wisconsin (MCW), Milwaukee, Wis (Kohlbeck, Akert, Pace, Zosel); Comprehensive Injury Center, MCW, Milwaukee, Wis (Kohlbeck, Akert).
Corresponding Author: Sara Kohlbeck, MPH, Medical College of Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226-0509; phone 414.955.7667; email skohlbeck@mcw.edu.
Funding/Support: Material development was funded by the Cooperative Agreement 5 NU17CE002741-02, Centers for Disease Control and Prevention (CDC). Its contents do not necessarily represent the official views of the CDC or the US Department of Health and Human Services.
Financial disclosures: None declared.